The Lancet Public Health is a leading journal in the field of public health, published by Elsevier since 2016. With its prominent Q1 quartile ranking in Public Health, Environmental and Occupational Health according to Scopus for 2023, and an impressive percentile ranking of 99th, the journal has established itself as a vital resource for researchers, professionals, and students committed to advancing public health knowledge and practices. Operating under an Open Access model, this journal ensures that groundbreaking research is readily accessible to all, promoting global collaboration and knowledge sharing. The scope of The Lancet Public Health encompasses diverse aspects of health, including the social determinants of health, epidemiology, health policy, and preventive medicine, making it a cornerstone for addressing contemporary public health challenges. Located in the heart of the United Kingdom, it aims to influence health policies and practices worldwide, showcasing transformative research and fostering vibrant discussions within the field.

PUBLIC HEALTH REPORTS is a premier journal in the field of public health, published by SAGE PUBLICATIONS INC in the United States. With its ISSN 0033-3549 and E-ISSN 1468-2877, this esteemed publication has been an influential voice in the discipline since its inception in 1945. Recognized for its rigorous scholarship, it currently holds a distinguished Q1 ranking in the 2023 category of Public Health, Environmental and Occupational Health, emphasizing its significance with a Scopus rank of #186 out of 665, placing it in the 72nd percentile. The journal aims to disseminate high-quality research that addresses pressing health issues and promotes evidence-based practices, making it a vital resource for researchers, professionals, and students alike. Although it is not an open-access journal, PUBLIC HEALTH REPORTS continues to offer extensive insights and advancements pertinent to the global public health landscape, thereby fostering a deeper understanding and engagement with critical health determinants. Researchers and health practitioners are encouraged to contribute to this dynamic forum where knowledge and innovation converge.

ANNALS OF EPIDEMIOLOGY, published by Elsevier Science Inc, stands as a leading journal in the field of epidemiology, with an impressive impact factor that reflects its significant contribution to public health research. With an ISSN of 1047-2797 and an E-ISSN of 1873-2585, the journal has been at the forefront of disseminating high-quality, peer-reviewed research since its inception in 1990. It is consistently ranked in the first quartile (Q1) for epidemiology in 2023, occupying the 29th position out of 148 in the Scopus Medicine category, with a percentage ranking in the 80th percentile. The journal aims to provide a comprehensive platform for the interdisciplinary exchange of pioneering epidemiological studies, exploring diverse health issues and their societal impacts. Researchers, professionals, and students alike will find valuable insights and innovative methodologies within its pages, making it an essential resource for anyone engaged in the study and application of epidemiology. Its headquarters located in the United States (STE 800, 230 Park Ave, New York, NY 10169) further reinforces its influence in the academic community.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

EPIDEMIOLOGIC REVIEWS, an esteemed publication from Oxford University Press Inc, stands as a beacon in the fields of Epidemiology and Medicine, with a significant focus on synthesizing and analyzing the latest research and developments in these areas since its inception in 1979. This journal, with its ISSN 0193-936X and E-ISSN 1478-6729, is recognized for its high academic rigor, boasting a 2023 Q1 quartile ranking in both Epidemiology and Miscellaneous Medicine, and ranks #25 out of 148 in Scopus's Epidemiology category, placing it in the prestigious 83rd percentile. Although it does not currently offer open access, its subscription options provide comprehensive access to a wealth of epidemiological knowledge, essential for researchers, public health professionals, and students keen on advancing their understanding of health trends and disease patterns. With a commitment to promoting high-quality research and impactful insights, EPIDEMIOLOGIC REVIEWS plays a crucial role in enhancing public health discourse and shaping future epidemiological inquiries.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Preventing Chronic Disease (ISSN: 1545-1151, E-ISSN: 1545-1151) is a premier open-access journal published by the CENTERS FOR DISEASE CONTROL & PREVENTION in the United States. Since its inception in 2004, this journal has played a vital role in disseminating research focused on the prevention of chronic diseases, offering insights into innovative public health strategies and policies. With a strong commitment to advancing health knowledge, it has achieved a notable impact factor that reinforces its significance—ranking in the Q1 category for both Health Policy and Public Health, Environmental, and Occupational Health as of 2023. With Scopus rankings placing it in the top 13% and 16% in its respective categories, Preventing Chronic Disease serves as a crucial platform for researchers, professionals, and students dedicated to combating chronic conditions. The journal's open-access model ensures that its valuable findings are accessible to a wide audience, fostering collaboration and innovation in public health research and practice.

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Journal of Public Health Research is a leading open-access journal published by SAGE Publications Inc., dedicated to advancing the field of public health. Since its inception in 2012, the journal has significantly contributed to the dissemination of knowledge in public health, environmental, and occupational health domains, ranking in the Q2 category in the 2023 Scopus metrics, with an impressive percentile of 59th among its peers. The journal aims to publish innovative research that explores critical health challenges and policy implications, fostering interdisciplinary collaboration among researchers, practitioners, and students. With an ISSN of 2279-9028 and an E-ISSN of 2279-9036, it is universally accessible, ensuring that vital findings reach a global audience. By providing a platform for impactful research set in the rich context of public health, the Journal of Public Health Research plays a crucial role in shaping public health practices and policies worldwide.